BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 28323122)

  • 41. Genomic landscape of lymphoepithelioma-like hepatocellular carcinoma.
    Chan AW; Zhang Z; Chong CC; Tin EK; Chow C; Wong N
    J Pathol; 2019 Oct; 249(2):166-172. PubMed ID: 31168847
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatic tumors induced by sex steroids.
    Mays ET; Christopherson W
    Semin Liver Dis; 1984 May; 4(2):147-57. PubMed ID: 6087460
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatocellular Carcinoma Arising in a Huge Hepatocellular Adenoma with Bone Marrow Metaplasia.
    Kang HJ; Jeong HJ; Kim SW; Yu E; Lee YJ; Kim SY; Kim J
    J Pathol Transl Med; 2018 Jul; 52(4):226-231. PubMed ID: 29281780
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus.
    Yeh TS; Wang F; Chen TC; Yeh CN; Yu MC; Jan YY; Chen MF
    Ann Surg; 2014 Feb; 259(2):346-54. PubMed ID: 24135722
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic Targeted Sequencing Panel for Hepatocellular Carcinoma Genomic Screening.
    Paradiso V; Garofoli A; Tosti N; Lanzafame M; Perrina V; Quagliata L; Matter MS; Wieland S; Heim MH; Piscuoglio S; Ng CKY; Terracciano LM
    J Mol Diagn; 2018 Nov; 20(6):836-848. PubMed ID: 30142445
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genomic profiling of well-differentiated hepatocellular neoplasms with diffuse glutamine synthetase staining reveals similar genetics across the adenoma to carcinoma spectrum.
    Joseph NM; Umetsu SE; Shafizadeh N; Ferrell L; Kakar S
    Mod Pathol; 2019 Nov; 32(11):1627-1636. PubMed ID: 31189995
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
    Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
    World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human liver tumors in relation to steroidal usage.
    Barrows GH; Christopherson WM
    Environ Health Perspect; 1983 Apr; 50():201-8. PubMed ID: 6307679
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clonal evolution in long-term follow-up patients with hepatocellular carcinoma.
    Chen G; Cai Z; Li Z; Dong X; Xu H; Lin J; Chen L; Zhang H; Liu X; Liu J
    Int J Cancer; 2018 Dec; 143(11):2862-2870. PubMed ID: 30183077
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genomic sequencing identifies a few mutations driving the independent origin of primary liver tumors in a chronic hepatitis murine model.
    Yang Z; Jia M; Liu G; Hao H; Chen L; Li G; Liu S; Li Y; Wu CI; Lu X; Wang S
    PLoS One; 2017; 12(11):e0187551. PubMed ID: 29117265
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multiple β-catenin mutations in hepatocellular lesions arising in Abernethy malformation.
    Sorkin T; Strautnieks S; Foskett P; Peddu P; Thompson RJ; Heaton N; Quaglia A
    Hum Pathol; 2016 Jul; 53():153-8. PubMed ID: 27038679
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Leptin receptor somatic mutations are frequent in HCV-infected cirrhotic liver and associated with hepatocellular carcinoma.
    Ikeda A; Shimizu T; Matsumoto Y; Fujii Y; Eso Y; Inuzuka T; Mizuguchi A; Shimizu K; Hatano E; Uemoto S; Chiba T; Marusawa H
    Gastroenterology; 2014 Jan; 146(1):222-32.e35. PubMed ID: 24055508
    [TBL] [Abstract][Full Text] [Related]  

  • 53. β-catenin (CTNNB1) mutations are not associated with prognosis in advanced hepatocellular carcinoma.
    Lu LC; Shao YY; Lee YH; Hsieh MS; Hsiao CH; Lin HH; Kao HF; Ma YY; Yen FC; Cheng AL; Hsu CH
    Oncology; 2014; 87(3):159-66. PubMed ID: 25012536
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatocellular carcinoma arising from hepatocellular adenoma in a hepatitis B virus-associated cirrhotic liver.
    Seo JM; Lee SJ; Kim SH; Park CK; Ha SY
    Clin Radiol; 2012 Apr; 67(4):329-33. PubMed ID: 22079485
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatocellular carcinoma coexisting with hepatic adenoma. Incidental discovery after long-term oral contraceptive use.
    Korula J; Yellin A; Kanel G; Campofiori G; Nichols P
    West J Med; 1991 Oct; 155(4):416-8. PubMed ID: 1663298
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
    Tornesello ML; Buonaguro L; Tatangelo F; Botti G; Izzo F; Buonaguro FM
    Genomics; 2013 Aug; 102(2):74-83. PubMed ID: 23583669
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular classification of hepatocellular adenoma in clinical practice.
    Nault JC; Paradis V; Cherqui D; Vilgrain V; Zucman-Rossi J
    J Hepatol; 2017 Nov; 67(5):1074-1083. PubMed ID: 28733222
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Kindlin-2 promotes hepatocellular carcinoma invasion and metastasis by increasing Wnt/β-catenin signaling.
    Lin J; Lin W; Ye Y; Wang L; Chen X; Zang S; Huang A
    J Exp Clin Cancer Res; 2017 Sep; 36(1):134. PubMed ID: 28969700
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls.
    Kelley RK; Magbanua MJ; Butler TM; Collisson EA; Hwang J; Sidiropoulos N; Evason K; McWhirter RM; Hameed B; Wayne EM; Yao FY; Venook AP; Park JW
    BMC Cancer; 2015 Mar; 15():206. PubMed ID: 25884197
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatocellular adenoma containing hepatocellular carcinoma in a male patient with familial adenomatous polyposis coli: Report of a case.
    Toiyama Y; Inoue Y; Yasuda H; Yoshiyama S; Araki T; Miki C; Kusunoki M
    Surg Today; 2011 Oct; 41(10):1442-6. PubMed ID: 21922375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.